Clinical Trials Browser

Carcinoma, Renal Cell, Neoplasm Metastasis, Wilms Tumor, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor

NCT00152906 2020-08-14

Stereotactic Radiotherapy (SRT) Liver (COLD 1)

Phase 1/2 Completed

140 enrolled

Gastrointestinal

Liver Neoplasms, Neoplasm Metastasis

NCT00777894 2019-05-15

Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Phase 1/2 Completed

18 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03446911 2018-02-27

Combining SBRT and Immunotherapy in Early Stage NSCLC Patients Planned for Surgery

Phase 1/2 Unknown

20 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00311597 2017-03-14

Extracranial Stereotactic Radiosurgery in Treating Patients With Solid Tumors

Phase 1/2 Completed

48 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00456612 2017-03-06

Radiosurgery for Glioblastoma Multiforme

Phase 1/2 Terminated

4 enrolled 3 charts

CNS

Glioblastoma

NCT00471835 2017-01-19

Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer

Phase 1/2 Withdrawn

Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00672178 2017-01-12

Stereotactic Body Radiotherapy (SBRT) and Sorafenib in Patients With Metastatic, Recurrent, or Unresectable Renal Cell Cancer (RCC)

Phase 1/2 Terminated

1 enrolled 4 charts

Genitourinary

Carcinoma, Renal Cell, Neoplasm Metastasis

NCT01304160 2016-08-05

Role of Cyberknife Stereotactic Radiation Therapy (SBRT) Followed by Gemcitabine for Patients With Locally Advanced Pancreatic Cancer

Phase 1/2 Completed

10 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT01020812 2016-07-27

Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma

Phase 1/2 Terminated

11 enrolled 8 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT00938457 2016-05-19

Stereotactic Radiation Therapy in Treating Patients With Liver Metastases

Phase 1/2 Terminated

3 enrolled 2 charts

Other solid neoplasm

Unspecified Adult Solid Tumor

NCT00888823 2016-03-16

Phase I/II Study of Fractionated Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung Cancer

Phase 1/2 Completed

13 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01586182 2015-09-04

Stereotactic Boost for Oropharyngeal Squamous Cell Carcinoma

Phase 1/2 Withdrawn

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT01222572 2015-06-04

Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer

Phase 1/2 Terminated

1 enrolled 4 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00238602 2012-07-13

Evaluation of Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Cancer

Phase 1/2 Completed

48 enrolled

Thoracic

Lung Neoplasms

NCT00185666 2010-07-14

Cyberknife Precision Radiation Delivery System for Tumors of the Spine

Phase 1/2 Completed

200 enrolled

Neoplasms, Neurologic Manifestations

Clinical Trials

DURABLE

ADORATION

Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies

Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases

SOLARA

Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases

Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.

BMS-986156, Ipilimumab, and Nivolumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Lung/Chest or Liver Cancers

LySATRA

Nivolumab and Radiation Therapy With or Without Ipilimumab in Treating Patients With Brain Metastases From Non-small Cell Lung Cancer

Evaluation of Single Session Stereotactic Body Radiotherapy

Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma

STILE

Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

ASCLEPIuS

SBRT-LDRT-Cadonilimab for Advanced Gastric, Colorectal and Ovarian Cancers With Peritoneal Metastases

Neurocognitive Decline in Patients With Brain Metastases

MacroTrans

Bintrafusp Alfa and Stereotactic Body Radiation Therapy for the Treatment of Recurrent or Second Primary Head and Neck Squamous Cell Cancer

CA209-9KH

SBRT Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC)

Microwave Ablation With MRI-Guided SBRT Boost in Renal Cell Carcinoma

WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain Metastases

Evaluating the Combination of MK-3475 and Sterotactic Body Radiotherapy in Patients With Metastatic Melanoma or NSCLC

Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma

Combining ICI With SBRT or HypoFrx-RT for ES NSCLC

Durvalumab, Tremelimumab and Hypofractionated Radiation Therapy in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer

FIBROPANC-1

Noelia

CROP

CSREIG

Tx-Treatment

Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors

Stereotactic Radiotherapy (SRT) Liver (COLD 1)

Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Combining SBRT and Immunotherapy in Early Stage NSCLC Patients Planned for Surgery

Extracranial Stereotactic Radiosurgery in Treating Patients With Solid Tumors

Radiosurgery for Glioblastoma Multiforme

Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer

Stereotactic Body Radiotherapy (SBRT) and Sorafenib in Patients With Metastatic, Recurrent, or Unresectable Renal Cell Cancer (RCC)

Role of Cyberknife Stereotactic Radiation Therapy (SBRT) Followed by Gemcitabine for Patients With Locally Advanced Pancreatic Cancer

Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma

Stereotactic Radiation Therapy in Treating Patients With Liver Metastases

Phase I/II Study of Fractionated Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung Cancer

Stereotactic Boost for Oropharyngeal Squamous Cell Carcinoma

Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer

Evaluation of Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Cancer

Cyberknife Precision Radiation Delivery System for Tumors of the Spine